± MEDIA & ARTS This study employs stylometry to investigate whether the creative writing styles of humans and large language…− MEDIA & ARTS With the rapid application of Generative AI technologies in image generation, style transfer, and creative as…± SCIENCE Using artificial intelligence to identify themes in interview data from a quality improvement program evaluat…+ HEALTH The accurate and rapid identification of bacterial pathogens is essential in clinical setups and medical biod…± HEALTH Introduction Transparency has emerged as a foundational condition for trustworthy Artificial Intelligence (AI…± HEALTH Background Global developmental delay (GDD) frequently precedes intellectual disability (ID), but no validate…− HEALTH Artificial intelligence (AI) tools are entering veterinary diagnostic laboratory service, but reported model…+ HEALTH Antimicrobial biocides play a crucial role in infection control. Although traditional detection methods are a…
TruaceTracing the truth around AITuesday, August 25, 2026
Subscribe
TRV-2026-0772Certified recordPeer-reviewed

Regulatory Research Priorities for AI Use in the Medicine Lifecycle: A European Perspective with Global Relevance

Regulatory bodies play a central role in providing guidance that enables safe and effective use of artificial intelligence tools in medicine development and evaluation. Regulators can also act as catalysts for regulatory science research. To inform these efforts, a European-wide survey was conducted to solicit stakeholder perspectives on the priority areas for regulatory science research related to the use of artificial intelligence in the medicine lifecycle. Twenty-eight regulatory science research questions we…

Policy · The Trace — both readings · certified 2026-08-15 · v1 · article view · machine-readable

Current reading — gain

Regulatory guidance enables safe and effective use of AI tools in medicine development and evaluation across the medicine lifecycle.

Current reading — problem

Stakeholders flag unresolved risks for AI in the medicine lifecycle around accuracy and reliability, data governance confidentiality and consent, and ethics fairness and bias prevention requiring further regulatory science research.

Evidence

Reader signal

How should this claim be treated?

Cite this record

Truvace Impact Record TRV-2026-0772, v1: “Regulatory Research Priorities for AI Use in the Medicine Lifecycle: A European Perspective with Global Relevance.” Truvace, 2026-08-15. /record/TRV-2026-0772 (accessed at citation time). sha256 0e36db183a71afeb…

Calibration history

Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.

  1. Certifiedv10e36db183a71…

    Certified into the record

Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0772 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.